Various other embodiments include a method of treating a form of cancer characterized by a high level of {HEAD ~ PTTG1} relative to {TAIL ~ a normal non cancerous subject}, comprising administering a therapeutically effective amount of a PTTG1 inhibitor, and administering a composition comprising a senescence inducing agent 
Various other embodiments include a method of treating a form of cancer characterized by a high level of { HEAD ~ PTTG1 } relative to { TAIL ~ a normal non cancerous subject } , comprising administering a therapeutically effective amount of a PTTG1 inhibitor , and administering a composition comprising a senescence inducing agent
OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH HEAD HEAD HEAD HEAD HEAD REL REL TAIL TAIL TAIL TAIL TAIL TAIL TAIL TAIL TAIL OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH